Insider · CIK 0001258288

COHEN RAYMOND W

Reports to the SEC for 9 companies · KIRKLAND, WA

sec.gov

Transactions

Companies

Filings

CIK

0001258288

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-30	KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.S Sale	Director	SSale	−3,330 sh	$29.28	−$97.5K	54,790
2026-09-09	KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.A Award	Director	AAward	+7,217 sh	—	—	58,120
2026-06-17	RXSTRxSight, Inc.A Award	Director	AAward	+30.9K sh	—	—	66,532
2026-03-26	KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.P Purchase	Director	PPurchase	+10K sh	$19.98	+$200K	50,903
2026-01-14	NSPRInspireMD, Inc.A Award	Director	AAward	+44K sh	—	—	92,417
2025-09-04	KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.A Award	Director	AAward	+10.9K sh	—	—	40,903
2025-07-31	RXSTRxSight, Inc.A Award	Director	AAward	+35.7K sh	—	—	35,668
2025-07-24	KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.A Award	Director	AAward	+13K sh	—	—	12,994
2025-03-07	KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.P Purchase	Director	PPurchase	+17K sh	$17.00	+$289K	29,994
2024-11-15	Axonics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−196K sh	$56.81	−$11.2M	0
2024-11-15	Axonics, Inc.Performance-Based Restricted Stock UnitsD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−31.1K sh	—	—	0
2024-11-15	Axonics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−107K sh	$69.37	−$7.41M	0
2024-11-15	Axonics, Inc.D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−293K sh	$71.00	−$20.8M	0
2024-07-24	Axonics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+25.8K sh	$14.19	+$366K	214,606
2024-07-24	Axonics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−25.8K sh	—	—	196,451
2024-07-24	Axonics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−78.1K sh	—	—	0
2024-07-24	Axonics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+78.1K sh	$25.82	+$2.02M	292,731
2024-01-31	Axonics, Inc.Performance-Based Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−21.9K sh	—	—	0
2024-01-31	Axonics, Inc.S Sale	Director, Chief Executive Officer	SSale	−35.2K sh	$67.74	−$2.38M	188,835
2024-01-31	Axonics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+63.4K sh	—	—	223,996
2024-01-31	Axonics, Inc.Performance-Based Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−41.5K sh	—	—	0
2023-02-01	Axonics, Inc.S Sale	Director, Chief Executive Officer	SSale	−6,932 sh	$61.02	−$423K	160,596
2023-02-01	Axonics, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,185 sh	$60.43	−$71.6K	167,528
2023-01-31	Axonics, Inc.A Award	Director, Chief Executive Officer	AAward	+20.8K sh	—	—	129,649
2023-01-31	Axonics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+62K sh	—	—	191,617
2023-01-31	Axonics, Inc.S Sale	Director, Chief Executive Officer	SSale	−9,032 sh	$61.12	−$552K	168,713
2023-01-31	Axonics, Inc.Performance-Based Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+41.5K sh	—	—	41,500
2023-01-31	Axonics, Inc.S Sale	Director, Chief Executive Officer	SSale	−13.9K sh	$61.17	−$849K	177,745
2023-01-31	Axonics, Inc.Performance-Based Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+20.8K sh	—	—	20,750
2023-01-31	Axonics, Inc.Performance-Based Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−40K sh	—	—	0
2023-01-31	Axonics, Inc.Performance-Based Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−22K sh	—	—	0
2023-01-13	Axonics, Inc.S Sale	Director, Chief Executive Officer	SSale	−22.1K sh	$66.27	−$1.46M	108,899
2023-01-13	Axonics, Inc.S Sale	Director, Chief Executive Officer	SSale	−18.7K sh	$65.54	−$1.22M	130,951
2022-08-08	Axonics, Inc.S Sale	Director, Chief Executive Officer	SSale	−18.1K sh	$69.50	−$1.26M	175,535
2022-08-08	Axonics, Inc.S Sale	Director, Chief Executive Officer	SSale	−12.1K sh	$70.40	−$851K	163,443
2022-08-08	Axonics, Inc.S Sale	Director, Chief Executive Officer	SSale	−12K sh	$71.65	−$862K	151,411
2022-08-08	Axonics, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,776 sh	$72.09	−$128K	149,635
2022-07-20	Axonics, Inc.G Gift	Director, Chief Executive Officer	GGift	−8,000 sh	—	—	152,596
2022-03-29	Axonics, Inc.S Sale	Director, Chief Executive Officer	SSale	−50K sh	$60.00	−$3M	193,635
2022-03-14	Axonics, Inc.S Sale	Director, Chief Executive Officer	SSale	−11.2K sh	$53.95	−$606K	260,535
2022-03-14	Axonics, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,981 sh	$52.66	−$104K	271,767
2022-03-14	Axonics, Inc.S Sale	Director, Chief Executive Officer	SSale	−17.8K sh	$50.42	−$897K	275,848
2022-03-14	Axonics, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,100 sh	$51.40	−$108K	273,748
2022-03-14	Axonics, Inc.S Sale	Director, Chief Executive Officer	SSale	−16.9K sh	$54.80	−$926K	243,635
2022-02-03	Axonics, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+96.8K sh	—	—	374,750
2022-02-03	Axonics, Inc.S Sale	Director, Chief Executive Officer	SSale	−33.3K sh	$48.21	−$1.61M	341,414
2022-02-03	Axonics, Inc.Performance-Based Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−54.3K sh	—	—	0
2022-02-03	Axonics, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,779 sh	$49.03	−$87.2K	339,635
2022-02-03	Axonics, Inc.Performance-Based Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−42.5K sh	—	—	0
2022-01-31	Axonics, Inc.A Award	Director, Chief Executive Officer	AAward	+43.3K sh	—	—	277,904

Recent filings

Accepted (ET)
Oct 14
COHEN RAYMOND W0001193125-26-410928
SEC(opens sec.gov)
Sep 104
COHEN RAYMOND W0001193125-26-388306
SEC(opens sec.gov)
Jun 184
COHEN RAYMOND W0001193125-26-275834
SEC(opens sec.gov)
Mar 304
COHEN RAYMOND W0001193125-26-132324
SEC(opens sec.gov)
Jan 164
COHEN RAYMOND W0001493152-26-002663
SEC(opens sec.gov)
Sep 84
COHEN RAYMOND W0000950170-25-113631
SEC(opens sec.gov)
Aug 44
COHEN RAYMOND W0000950170-25-102098
SEC(opens sec.gov)
Jul 244
COHEN RAYMOND W0000950170-25-098339
SEC(opens sec.gov)
Nov 154
COHEN RAYMOND W0001562180-24-007702
SEC(opens sec.gov)
Jul 254
COHEN RAYMOND W0001562180-24-005843
SEC(opens sec.gov)
Feb 24
COHEN RAYMOND W0001562180-24-001009
SEC(opens sec.gov)

Companies

Address

C/O KESTRA MEDICAL TECHNOLOGIES LTD. 3933 LAKE WASHINGTON BLVD NE, SUITE 200

KIRKLAND, WA, 98033